Pharmaceutical care program in HIV patients under antiretroviral treatment: Methodology and documentation;Programa de atención farmacéutica a pacientes VIH con tratamiento antirretroviral: Metodología y documentación

Farmacia Hospitalaria

Volumn 28, Issue 6 SUPPL. 1, 2004, Pages 72-79

  Ventura Cerdá, José Manuel ^a   Alos Alminana M ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

Acquired immunodeficiency syndrome; Anti HIV agents; Drug therapy; HIV; Methods; Outcome assessment; Pharmaceutical care

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR DISOPROXIL; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL PHARMACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SATISFACTION; PHARMACIST; PRESCRIPTION; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HUMANS; PHARMACY SERVICE, HOSPITAL; RECORDS;

EID: 14644422289     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. American Society of Hospital Pharmacy. ASHP statement on the pharmacist's role in the care of patients with HIV infection. Am J Health-Syst Pharm 2003; 60: 1998-2003.
2. American Society of Hospital Pharmacy. ASHP guidelines on documenting pharmaceutical care in patient medical records. Am J Health-Syst Pharm 2003; 60: 705-7.
3. Baldominos G, Castillo I. Recomendaciones para el desarrollo de Atención Farmacéutica a pacientes externos. Comisión de normas y procedimientos de la SEFH, Sociedad Española de Farmacia Hospitalaria, Junio 2002. www.sefh.es.
4. Codina C, Delgado O. Recomendaciones para desarrollar un programa de atención farmacéutica al paciente VIH. Comisión de normas y procedimientos de la SEFH, Sociedad Española de Farmacia Hospitalaria, Junio 2001. www.sefh.es.
5. American Society of Health-System Pharmacists. ASHP guidelines on a standarized method for pharmaceutical care. Am J Health-Syst Pharm 1996; 53: 1713-6.
6. American Society of Health-System Pharmacists. ASHP guidelines: minimum standard for pharmaceutical services in ambulatory care. Am J Health-Syst Pharm 1999; 56: 1744-53.
7. Bieszk N, Patel R, Heaberlin A, Wlasuk K, Zarowitz B. Detection of medication nonadherence through review of pharmacy claims data. Am J Health-Syst Pharm 2003; 60: 360-6.
8. a ed. Valencia: AFAHPE (asociación de farmacéuticos del hospital doctor Peset); 2002.
9. Le Moing V, Chêne G, Carrieri MP, Alioum A, Brun-Vézinet F, Piroth L, et al. Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS 2002; 16: 21-9.
10. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistanse. JAMA 1998; 279: 1977-83.
11. Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEMA study. AIDS 2002; 16: 605-13.
12. Gao X, Nau DP. Congruence of three self-report measures of medication adherence among HIV patients. Ann Pharmacother 2000; 34: 1117-22.
13. Climente-Martf M, Font-Noguera I, Jiménez-Torres NV. Procedimientos para la práctica clínica orientada a problemas farmacoterapéuticos. Rev Calidad Asistencial 2001; 16: 343-53.
14. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001; 33: 337-43.
15. Albert A, Sancho V, Llopis P, Calipienso R, Jiménez NV. Aplicación informática para documentar las actividades de atención farmacéutica. Aten Farm 1999; 1: 217-32.
16. Carmona A, Ribes E, Salas E. Unidad de dispensación ambulatoria para el tratamiento antirretroviral: atención farmacéutica. El Farmacéutico Hospitales 2004; 150: 30-6.
17. Geletko SM, Poulakos MN. Pharmaceutical services in an HIV clinic. Am J Health-Syst Pharm 2002; 59: 709-13.